Drug-drug Interaction Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Subjects With Castration-Resistant Prostate Cancer

Trial Profile

Drug-drug Interaction Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Subjects With Castration-Resistant Prostate Cancer

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Apalutamide (Primary) ; Fexofenadine; Midazolam; Omeprazole; Pioglitazone; Rosuvastatin; Vitamin K; Warfarin
  • Indications Prostate cancer
  • Focus Pharmacokinetics
  • Sponsors Aragon Pharmaceuticals
  • Most Recent Events

    • 17 Mar 2017 Status changed from recruiting to active, no longer recruiting.
    • 17 Feb 2017 Planned End Date changed from 1 Nov 2018 to 1 Jul 2018.
    • 19 Oct 2016 Planned primary completion date changed from 1 Oct 2018 to 1 Nov 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top